Cook Medical said it promoted Jean-Marc Creissel to vice president of its urology business, which Creissel has led since 2010.
ArtVentive Medical Group Inc.
MassDevice.com +3 | The top 3 med-tech stories for June 19, 2013
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
ArtVentive Medical wins CE Mark for peripheral catheter
ArtVentive Medical Group (OTC:AVTD) announced plans to launch its EOS peripheral vascular endoluminal occlusion system in the European Union following CE Mark approval for the self-expanding catheter device.
Sleep apnea: ImThera touts tongue stimulation treatment | Research roundup
ImThera Medical Inc. said its tongue stimulation device for sleep apnea can improve patients’ snooze time.
The San Diego-based device maker concluded a European pilot study of its aura6000, an implanted neurostimulation device for treating obstructive sleep apnea (OSA) that delivers electrical pulses to the tongue during sleep.
ArtVentive freezes development on endoluminal occlusion device
ArtVentive Medical Group Inc. (OTC:AVTD) froze the design process for its Endoluminal Occlusion device, saying it’s gearing up to seek regulatory approvals ahead of launching the product in Europe and the U.S.
The San Marcos, Calif.-based company it also has its eye on Eastern Europe, Japan, Asia Pacific and Latin America.
Ohio-funded Israeli medtech firm closes $10 million IPO | Funding roundup
An Israeli medical device company backed by a Northeast Ohio venture capital firm has raised more than $10 million in an initial public offering on the Tel Aviv Stock Exchange.
Now the company, IceCure Ltd., is exploring whether to set up its U.S. sales and marketing headquarters in Northeast Ohio, though CEO Hezi Himelfarb stressed that no final decision has been made. But Northeast Ohio would seem to have a leg up on the competition because it’s the home of the Bridge Investment Fund, which has invested more than $1 million in IceCure since 2008.
ArtVentive inks deal with clinical and regulatory strategy firm
ArtVentive Medical Group Inc. (OTC:AVTD) signed an agreement with Northwest Clinical Research Group Inc. to prepare for regulatory processes in the U.S. and abroad.
The deal provides for Woodinvill, Wash.-based NCRG to assist ArtVentive in building its quality systems and securing Food & Drug Administration and European CE Mark approvals.
ArtVentive and Medical Murray ink development deal
ArtVentive Medical Group Inc. (OTC:AVTD) entered into a development and manufacturing agreement with North Barrington, Ill.-based Medical Murray Inc.
The San Marcos, Calif.-based endoluminal occlusion device-maker said the collaboration should reduce development time for its products.
